Pharmaceutical Policies in the Biden Agenda

Abstract

The article provides an analysis of the pharmaceutical policy under the Biden Administration. The focus is on Executive Orders and measures in some key areas such as: lowering prescription drug costs for Americans; strengthening Americans’ access to health coverage; addressing reproductive health and the distribution of abortion pills (a very relevant issue, especially after the US Supreme Court judgment which overruled the leading case Roe versus Wade of 1973).

Keywords: Pharmaceutical policy; US Government; Biden Presidency; Drug costs; Health coverage; Distribution of abortion pill